Caisse de depot et placement du Quebec

Position in HALO — Halozyme Therapeutics, Inc.

CIK 898286 Montreal, A8

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$83,939,800

+$11,476,644 QoQ

Shares Held

1,072,439

-4.3% QoQ

Ownership

0.945%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#37

of 667 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Caisse de depot et placement du Quebec holds $670,874,502 across 12 Biotechnology names. HALO ranks #4 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	250,608	$156,264,112
2	INCY	Incyte Corp	1,370,503	$155,360,220
3	EXEL	Exelixis, Inc.	2,094,299	$113,950,808
4	HALO	Halozyme Therapeutics, Inc. This page	1,072,439	$83,939,800
5	BMRN	Biomarin Pharmaceutical Inc	1,236,446	$70,749,440
6	RPRX	Royalty Pharma plc	1,003,953	$56,291,644
7	ALNY	Alnylam Pharmaceuticals, Inc.	85,748	$25,812,720
8	VRTX	Vertex Pharmaceuticals Inc / Ma	13,042	$6,478,352

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$83,939,800	1,072,439	-4.3%	Shares	Sole	2026-08-14
2026-03-31	$72,463,156	1,121,200	-8.4%	Shares	Sole	2026-05-14
2025-12-31	$82,375,805	1,224,009	+57.6%	Shares	Sole	2026-02-17
2025-09-30	$56,958,410	776,635	-42.1%	Shares	Sole	2025-11-14
2025-06-30	$69,770,264	1,341,220	+47.4%	Shares	Sole	2025-08-14
2025-03-31	$58,077,883	910,169	+154.5%	Shares	Sole	2025-05-14
2024-12-31	$17,095,851	357,579	+280.4%	Shares	Sole	2025-02-14
2024-09-30	$5,381,075	94,009	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.